Last week, Tom Frieden, director of the U.S. Centers for Disease Control and Prevention, held an unusual press conference to discuss three separate, recent mistakes
involving lab safety with smallpox, influenza, and anthrax.
Further developments are clearly forthcoming
involving both lab safety and the UC contract.
Not exact matches
Last week, a bipartisan pair of U.S. senators introduced a bill that would streamline the red tape
involved in studying potential bioweapons as well as address
safety concerns at the nation's biodefense
labs.
Influenza scientists working in nations that have finalized funding and
lab safety rules should now be free to resume experiments that
involve reengineering the virus, they write.